Lucid Diagnostics (LUCD) Other Operating Expenses (2020 - 2026)

Lucid Diagnostics (LUCD) has reported Other Operating Expenses for 7 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses fell 6.19% year-over-year to $2.7 million; the trailing twelve-month figure through Jun 2026 stood at $12.4 million (down 5.51% YoY), and the FY2025 full-year result was $12.8 million, down 7.33% from the prior year.
• Other Operating Expenses declined to $2.7 million in Q2 2026 per LUCD's latest filing, from $2.9 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $4.8 million in Q3 2022 and bottomed at $2.7 million in Q2 2026.
• Historically, Other Operating Expenses has averaged $3.6 million across 5 years, with a median of $3.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses soared 371.7% in 2022, then declined 22.36% in 2023.
• Over 5 years, Other Operating Expenses stood at $4.6 million in 2022, then decreased by 15.01% to $3.9 million in 2023, then decreased by 4.54% to $3.7 million in 2024, then fell by 0.43% to $3.7 million in 2025, then decreased by 25.65% to $2.7 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $2.7 million, $2.9 million, and $3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.